# RLMD (Relmada Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Relmada Therapeutics, Inc. reported $205.3M in total assets and a net loss of $65.70M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/RLMD
- Markdown: https://convexityos.com/fundamentals/RLMD.md
- SEC CIK: 0001553643
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:37 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001553643&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$67.90M | Operating profit |
| Net Income | FY 2025 | -$65.70M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.58 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $202.1M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $26.88M | $46.18M | $54.81M | $113.3M | $90.62M | $35.97M | $7.86M | $7.02M | $2.94M | $1.29M |
| Total Operating Expenses | $59.10M | $83.89M | $103.7M | $161.2M | $125.7M | $60.84M | $15.11M | $12.73M | $6.92M | $7.22M |
| **Operating Income** | -$59.10M | -$83.89M | -$103.7M | -$161.2M | -$125.7M | -$60.84M | -$15.11M | -$12.73M | -$6.92M | -$7.22M |
| **EBITDA** | -- | -- | -- | -- | -$125.7M | -$60.83M | -$15.10M | -$12.72M | -$6.91M | -$7.13M |
| Interest Income | $1.40M | $3.53M | $5.15M | -- | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$57.39M | -$79.98M | -$98.79M | -$157.0M | -$125.8M | -$59.46M | -$15.01M | -$17.32M | -$8.96M | -$6.29M |
| Basic EPS | -$1.45 | -$2.65 | -$3.28 | -$5.30 | -$7.16 | -$3.81 | -$1.62 | -$2.74 | -$0.71 | -$0.52 |
| **Diluted EPS** | -$1.45 | -$2.65 | -$3.28 | -$5.30 | -$7.16 | -$3.81 | -$1.62 | -$2.74 | -$0.71 | -$0.52 |
| Basic Shares Outstanding | 39.5M | 30.2M | 30.1M | 29.6M | 17.6M | 15.6M | 9.2M | 6.3M | 12.5M | 12.1M |
| Diluted Shares Outstanding | 39.5M | 30.2M | 30.1M | 29.6M | 17.6M | 15.6M | 9.2M | 6.3M | 12.5M | 12.1M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $9.22M | $8.39M | $8.09M | $8.07M | $4.04M | $2.82M | $11.95M | $11.00M |
| Total Operating Expenses | $13.10M | $15.01M | $19.46M | $20.33M | $10.33M | $10.22M | $18.22M | $19.08M |
| **Operating Income** | -$13.10M | -$15.01M | -$19.46M | -$20.33M | -$10.33M | -$10.22M | -$18.22M | -$19.08M |
| Interest Income | $2.27M | $2.30M | $960K | $387K | $247K | $321K | $440K | $655K |
| **Net Income** | -$13.86M | -$12.91M | -$19.05M | -$19.87M | -$10.09M | -$9.87M | -$17.56M | -$18.66M |
| Basic EPS | -$0.12 | -$0.11 | -$0.22 | -- | -$0.30 | -$0.30 | -$0.58 | -- |
| **Diluted EPS** | -$0.12 | -$0.11 | -$0.22 | -- | -$0.30 | -$0.30 | -$0.58 | -- |
| Basic Shares Outstanding | 112.4M | 112.4M | 86.6M | -- | 33.2M | 33.2M | 30.4M | -- |
| Diluted Shares Outstanding | 112.4M | 112.4M | 86.6M | -- | 33.2M | 33.2M | 30.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.50M | $3.86M | $4.09M | $5.40M | $44.44M | $2.50M | $36.28M | $9.22M | $2.24M | $1.71M |
| Short-Term Investments | $89.51M | $41.05M | $92.23M | $142.9M | $167.5M | $114.6M | $80.16M | -- | -- | -- |
| **Cash & Short-Term Investments** | $93.01M | $44.91M | $96.32M | $148.3M | $211.9M | $117.1M | $116.4M | $9.22M | $2.24M | $1.71M |
| Accounts Receivable, Net | -- | -- | -- | $512K | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $93.98M | $45.80M | $97.51M | $152.9M | $223.3M | $118.1M | $116.9M | $9.98M | $2.74M | $2.47M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | $1.3K | $5.0K | $7.2K | $12K | $2.3K |
| Other Non-Current Assets | $20K | $22K | $43K | $35K | $28K | $25K | $25K | $25K | $25K | $22K |
| **Total Non-Current Assets** | $20K | $22K | $43K | $35K | $28K | $113K | $196K | $235K | $310K | $362K |
| **Total Assets** | $94.00M | $45.82M | $97.55M | $152.9M | $223.3M | $118.2M | $117.1M | $10.22M | $3.05M | $2.84M |
| Accounts Payable | $1.57M | $4.13M | $3.51M | $5.26M | $11.19M | $8.35M | $523K | $924K | $765K | $530K |
| **Total Current Liabilities** | $6.43M | $10.29M | $12.19M | $12.47M | $15.06M | $12.60M | $1.46M | $2.61M | $5.90M | $1.38M |
| **Total Non-Current Liabilities** | $1.06M | $4.5K | $0 | $0 | $0 | $0 | $0 | $0 | $2.66M | $0 |
| **Total Liabilities** | $7.49M | $10.30M | $12.19M | $12.47M | $15.06M | $12.60M | $1.46M | $2.61M | $8.56M | $1.38M |
| Common Stock | $73K | $30K | $30K | $30K | $28K | $16K | $14K | $9.7K | $13K | $13K |
| Retained Earnings | -$698.3M | -$640.9M | -$560.9M | -$462.1M | -$305.1M | -$179.3M | -$119.9M | -$111.7M | -$94.34M | -$85.38M |
| **Total Stockholders' Equity** | $86.51M | $35.52M | $85.36M | $140.4M | $208.3M | $105.6M | $115.7M | $7.61M | -$5.51M | $1.46M |
| Total Equity | $86.51M | $35.52M | $85.36M | $140.4M | $208.3M | $105.6M | $115.7M | $7.61M | -$5.51M | $1.46M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.72M | $11.33M | $9.78M | $3.50M | $1.38M | $1.35M | $1.15M | $3.86M |
| Short-Term Investments | $196.4M | $206.4M | $224.2M | $89.51M | $12.50M | $19.27M | $25.91M | $41.05M |
| **Cash & Short-Term Investments** | $202.1M | $217.7M | $234.0M | $93.01M | $13.89M | $20.62M | $27.06M | $44.91M |
| **Total Current Assets** | $205.0M | $219.0M | $235.3M | $93.98M | $14.85M | $21.09M | $27.66M | $45.80M |
| Other Non-Current Assets | $247K | $20K | $20K | $20K | $22K | $22K | $22K | $22K |
| **Total Non-Current Assets** | $247K | $20K | $20K | $20K | $22K | $22K | $22K | $22K |
| **Total Assets** | $205.3M | $219.1M | $235.4M | $94.00M | $14.88M | $21.12M | $27.68M | $45.82M |
| Accounts Payable | $2.54M | $2.41M | $5.73M | $1.57M | $1.45M | $1.36M | $1.27M | $4.13M |
| **Total Current Liabilities** | $7.78M | $7.42M | $12.89M | $6.43M | $5.19M | $5.13M | $5.23M | $10.29M |
| **Total Non-Current Liabilities** | $3.78M | $5.08M | $3.74M | $1.06M | $221K | $32K | $7.5K | $4.5K |
| **Total Liabilities** | $11.56M | $12.50M | $16.63M | $7.49M | $5.41M | $5.17M | $5.24M | $10.30M |
| Common Stock | $107K | $107K | $105K | $73K | $33K | $33K | $33K | $30K |
| Retained Earnings | -$744.1M | -$730.2M | -$717.3M | -$698.3M | -$678.4M | -$668.3M | -$658.4M | -$640.9M |
| **Total Stockholders' Equity** | $193.7M | $206.6M | $218.7M | $86.51M | $9.47M | $15.95M | $22.44M | $35.52M |
| Total Equity | $193.7M | $206.6M | $218.7M | $86.51M | $9.47M | $15.95M | $22.44M | $35.52M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$57.39M | -$79.98M | -$98.79M | -$157.0M | -$125.8M | -$59.46M | -$15.01M | -$17.32M | -$8.96M | -$6.29M |
| Depreciation & Amortization | -- | -- | -- | -- | $1.3K | $3.8K | $4.4K | $4.9K | $2.6K | $85K |
| Stock-Based Compensation | $13.91M | $30.18M | $43.81M | $44.19M | $40.49M | $20.78M | $3.17M | $1.21M | $518K | $704K |
| Change in Receivables | -- | -- | -- | -$512K | -- | -- | -- | -- | -- | -- |
| Change in Payables | -$2.56M | $625K | -$1.76M | $421K | $2.85M | $7.82M | $164K | $159K | $157K | -$730K |
| **Operating Cash Flow** | -$45.79M | -$51.76M | -$51.66M | -$103.8M | -$91.87M | -$27.81M | -$12.09M | -$10.50M | -$6.00M | -$6.47M |
| Capital Expenditure | -- | -- | -- | -- | -- | -$182.1M | -$84.85M | -- | -$12K | -$50K |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -$209.9M | -$96.94M | -- | -$6.01M | -$6.52M |
| Purchases of Investments | -- | -- | -- | -$47.29M | -$223.0M | -$182.1M | -- | -- | -- | -- |
| **Investing Cash Flow** | -$48.14M | $51.56M | $50.45M | $19.73M | -$54.12M | -$34.45M | -$80.16M | -- | -$12K | -$50K |
| Common Stock Issued | $93.64M | -- | -- | $42.73M | $184.6M | $19.79M | -- | $17.84M | -- | -- |
| **Financing Cash Flow** | $93.56M | -$40K | -$98K | $45.02M | $187.9M | $28.47M | $126.1M | $17.48M | $6.54M | -$274K |
| **Net Change in Cash** | -$360K | -$235K | -$1.30M | -$39.05M | $41.95M | -$33.78M | $33.85M | $6.98M | $528K | -$6.79M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$13.86M | -$12.91M | -$19.05M | -$19.87M | -$10.09M | -$9.87M | -$17.56M | -$18.66M |
| Stock-Based Compensation | $1.02M | $903K | $956K | $3.28M | $3.61M | $3.45M | $3.57M | $6.73M |
| Change in Payables | $129K | -$922K | $1.76M | $116K | $91K | $97K | -$2.87M | $1.79M |
| **Operating Cash Flow** | -$12.59M | -$9.61M | -$15.07M | -$14.60M | -$6.72M | -$6.40M | -$18.07M | -$8.80M |
| **Investing Cash Flow** | $6.95M | $17.59M | -$135.2M | -$76.93M | $6.75M | $6.68M | $15.36M | $11.35M |
| Share Repurchases | $0 | -$6.46M | -$3.36M | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $18K | -$6.42M | $156.6M | -- | -- | -- | -- | -$172K |
| **Net Change in Cash** | -$5.61M | $1.56M | $6.28M | $2.11M | $31K | $204K | -$2.71M | $2.37M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -66.3% | -225.2% | -115.7% | -111.8% | -60.4% | -56.3% | -13.0% | -227.5% | -- | -430.5% |
| Return on Assets (ROA) | -61.0% | -174.6% | -101.3% | -102.7% | -56.3% | -50.3% | -12.8% | -169.5% | -294.0% | -221.6% |
| Current Ratio | 14.62x | 4.45x | 8.00x | 12.26x | 14.83x | 9.37x | 80.21x | 3.83x | 0.46x | 1.80x |
| Quick Ratio | 14.46x | 4.36x | 7.90x | 11.94x | 14.07x | 9.29x | 79.87x | 3.54x | 0.38x | 1.24x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -33.9% | -30.0% | -26.9% | -66.3% | -593.5% | -425.1% | -337.4% | -225.2% |
| Return on Assets (ROA) | -32.0% | -28.3% | -25.0% | -61.0% | -377.6% | -321.1% | -273.5% | -174.6% |
| Current Ratio | 26.37x | 29.52x | 18.26x | 14.62x | 2.86x | 4.11x | 5.29x | 4.45x |
| Quick Ratio | 25.99x | 29.34x | 18.15x | 14.46x | 2.68x | 4.02x | 5.17x | 4.36x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
